-
Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
21 Aug 2025 16:11 GMT
… treatment of non-small cell lung cancer (NSCLC), the Company was granted … , is the first-ever redosable gene therapy, and the first genetic medicine …
-
Boehringer Ingelheim & AnGes sign manufacturing agreement for HGF gene therapy product
21 Aug 2025 05:43 GMT
… Hepatocyte Growth Factor (HGF) gene therapy product. The plasmid DNA … ) is second only to lung cancer (80%). In addition, The … starting treatment with HGF gene therapy product for patients with PAD … the development of HGF gene therapy product and contribute to …
-
Boehringer Ingelheim, AnGes Ink Manufacturing Deal for HGF Gene Therapy
20 Aug 2025 13:06 GMT
… investigational Hepatocyte Growth Factor (HGF) gene therapy aimed at treating Peripheral Arterial … major amputations rivals that of lung cancer, emphasizing the urgent need for … and commercialization of AnGes’ HGF gene therapy and strengthen the companies’ …
-
Genprex receives US & European patents for Reqorsa gene therapy with PD─L1 and PD─1 antibodies to treat cancers
19 Aug 2025 11:50 GMT
… Inc., a clinical-stage gene therapy company focused on developing life … lead drug candidate, Reqorsa gene therapy, in combination with PD … extensive stage small cell lung cancer (ES-SCLC) who … is a clinical-stage gene therapy company focused on developing …
-
Loading of Enzymatic Cargos into Extracellular Vesicles Derived from Lung Cancer Cells
14 Aug 2025 12:47 GMT
… extracellular vesicles on pristine lung cancer cells (A549), … molecular biotargets in lung cancer cells. ACS Appl … al. Prodrug suicide gene therapy for cancer targeted intracellular … al. Exosomes derived from lung cancer cells: isolation, characterization, …
-
Breakthrough Delivers Cystic Fibrosis Gene Therapy to Lungs
28 Jul 2025 22:34 GMT
RT’s Three Key Takeaways:
Targeted Lung Delivery — Scientists developed a novel nanoparticle system capable of safely delivering genetic therapies like mRNA and gene-editing tools directly to lung cells.
Therapeutic Success in Mice — In mouse models, the …
-
Global Lung Cancer Treatment Market Size, Trends, Growth Forecast 2025–2033 | DataM Intelligence
17 Jun 2025 12:45 GMT
… as checkpoint inhibitors and gene therapy, improves the efficacy … contributing significantly to lung cancer incidence, healthcare systems … -Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
… Conclusion:
The global lung cancer treatment market is …
-
10 Year Non-small Cell Lung Cancer Seven-Market Drug Forecast and Market Analysis 2022-2032: Focus on US, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com
18 Jun 2025 18:49 GMT
… "Non-small Cell Lung Cancer: Seven-Market Drug Forecast … cases of Non-small Cell Lung Cancer (NSCLC) to be … market for non-small cell lung cancer (NSCLC).
These sales … NMIBC
Competitive Assessment - Gene Therapies for NMIBC
Competitive Assessment …
-
Theranostic Role of Advanced Nanotechnological Tools in Early Brain Metastases in Lung Cancer: An Updated Review
05 Jun 2025 21:28 GMT
… cells from the initial lung tumor, their migration into … Brain Metastasis in Lung Cancer. Primary lung cancer cells move from … In contrast to original lung tumors, which might manifest … therapeutic approaches, such as gene therapy and chemotherapy, thereby …
-
Advances of Drug-Loaded Microsphere Technology for Targeted Immunotherapy Against Prostate Cancer
19 Sep 2025 16:43 GMT
… sequential chemotherapy with apatinib in lung cancer-bearing mice and patients. Cancer … . mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer. Cancer Res …